US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Inhibrx Biosciences

103.63

+4.484.52%

Post-market: 103.630.00000.00%19:30 EDT

Volume:220.74K

Turnover:22.72M

Market Cap:1.52B

PE:-11.67

High:105.65

Open:100.76

Low:99.05

Close:99.15

52wk High:155.29

52wk Low:24.00

Shares:14.67M

Float Shares:8.42M

Volume Ratio:0.75

T/O Rate:2.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-8.8768

EPS(LYR):-9.0434

ROE:-1773.60%

ROA:-43.61%

PB:-28.70

PE(LYR):-11.46

Loading ...

Overview Company News Filings

Inhibrx Biosciences - FDA Sets Pdufa Goal Date of April 14, 2027 for Ozekibart Bla

THOMSON REUTERS

Inhibrx Biosciences Holds 2026 Virtual Annual Shareholder Meeting

Inhibrx Biosciences shareholders elect two Class II directors at annual meeting

Transcenta Gains Boost as Inhibrx’s Ozekibart Data and FDA Filing Strengthen Greater China Cancer Franchise

LifeSci Capital Reaffirms Their Buy Rating on Inhibrx Biosciences Inc (INBX)

Inhibrx price target raised to $325 from $300 at Stifel

Stifel Nicolaus Sticks to Their Buy Rating for Inhibrx Biosciences Inc (INBX)

Inhibrx Biosciences Inc : Stifel Raises Target Price to $325 From $300

THOMSON REUTERS

Inhibrx reports Q1 EPS ($2.15) vs. ($2.80) last year

Inhibrx Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Inhibrx Biosciences Q1 EPS $(2.15) Misses $(1.79) Estimate

Benzinga Earnings

Inhibrx Q1 net loss narrows as R&D costs fall

Inhibrx net loss narrows 23% to $33.44 million in Q1 2026

Inhibrx Q1 Net Income USD -33.441 Million

THOMSON REUTERS

Inhibrx Q1 Operating Income USD -30.927 Million

THOMSON REUTERS

Should Positive INBRX-106 Phase 2 Combo Data in Head and Neck Cancer Require Action From Inhibrx Biosciences (INBX) Investors?

Simply Wall St.

Inhibrx Biosciences Reports Positive Interim Phase 2 Results

Inhibrx’s INBRX-106 shows potential benefit in HNSCC

Inhibrx says INBRX-106 plus pembrolizumab lifts Phase 2 HNSCC response rate to 44%

Inhibrx Reports Interim Phase 2 Data for Inbrx-106 in First-Line Hnscc; Initial Results Demonstrate Potential Costimulatory Benefit Over Pd-1 Monotherapy

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/INBX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"INBX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INBX\",,,,,undefined,":{"symbol":"INBX","market":"US","secType":"STK","nameCN":"Inhibrx Biosciences","latestPrice":103.63,"timestamp":1787342400000,"preClose":99.15,"halted":0,"volume":220744,"hourTrading":{"tag":"盘后","latestPrice":103.63,"preClose":103.63,"latestTime":"19:30 EDT","volume":311,"amount":32228.93,"timestamp":1787355006778,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.045184064548663534,"floatShares":8415900,"shares":14671186,"eps":-8.876818,"marketStatus":"Market Closed","change":4.48,"latestTime":"08-21 16:00:00 EDT","open":100.76,"high":105.65,"low":99.05,"amount":22716076.31872,"amplitude":0.066566,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.876818,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":99.15,"preHourTrading":{"tag":"盘前","latestPrice":100.27,"preClose":99.15,"latestTime":"09:22 EDT","volume":2265,"amount":225665.77785,"timestamp":1787318579516,"change":1.12,"changeRate":0.011296,"amplitude":0.053964},"postHourTrading":{"tag":"盘后","latestPrice":103.63,"preClose":103.63,"latestTime":"19:30 EDT","volume":311,"amount":32228.93,"timestamp":1787355006778,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7490937673615714,"impliedVol":1.1148,"impliedVolPercentile":0.6096},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INBX\",,,,,undefined,":{"symbol":"INBX","floatShares":8415900,"roa":"-43.61%","roe":"-1773.60%","lyrEps":-9.043391,"volumeRatio":0.7490937673615714,"shares":14671186,"dividePrice":0,"high":105.65,"amplitude":0.066566,"preClose":99.15,"low":99.05,"week52Low":24,"pbRate":"-28.70","week52High":155.29,"institutionHeld":0,"latestPrice":103.63,"eps":-8.876818,"divideRate":0,"volume":220744,"delay":0,"ttmEps":-8.876818,"open":100.76,"prevYearClose":79,"prevWeekClose":88.37,"prevMonthClose":82.05,"prevQuarterClose":94.75,"fiveDayClose":88.37,"twentyDayClose":81.55,"sixtyDayClose":103},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INBX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"INBX","fiscalQuarterEnding":"2026/06","expectedEps":-2.5,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-2.34},{"market":"US","date":"2026-05-14","symbol":"INBX","fiscalQuarterEnding":"2026/03","expectedEps":-2.37,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-2.15},{"market":"US","date":"2026-03-19","symbol":"INBX","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"post","actualEps":-2.11},{"market":"US","date":"2025-11-14","symbol":"INBX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-2.28},{"market":"US","date":"2025-08-13","symbol":"INBX","fiscalQuarterEnding":"2025/06","expectedEps":-2.92,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-1.85}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INBX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INBX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":3,"updateTime":1777089600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INBX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INBX","date":"2026-08-21","current":-11.674228,"percent":0.173878,"low":-22.314917,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"high":0.20643,"avg":-6.710354,"sd":5.168897,"marketCap":1459255989},"quantilePoints":[{"date":"2021-08-27","current":-14.469299,"twenty":-15.305844,"median":-11.921916,"eighty":-8.89072,"marketCap":1130703367},{"date":"2021-09-03","current":-15.225737,"twenty":-15.25037,"median":-12.221226,"eighty":-8.940031,"marketCap":1189815205},{"date":"2021-09-10","current":-16.530107,"twenty":-15.521886,"median":-12.271925,"eighty":-8.940445,"marketCap":1291745234},{"date":"2021-09-17","current":-17.950853,"twenty":-15.909368,"median":-12.434577,"eighty":-8.944079,"marketCap":1402769392},{"date":"2021-09-24","current":-17.829629,"twenty":-16.480889,"median":-12.612787,"eighty":-8.953333,"marketCap":1393296341},{"date":"2021-10-01","current":-15.730029,"twenty":-16.490733,"median":-12.663254,"eighty":-8.96336,"marketCap":1229223097},{"date":"2021-10-08","current":-12.97097,"twenty":-16.480889,"median":-12.827884,"eighty":-9.035825,"marketCap":1013616457},{"date":"2021-10-15","current":-19.255223,"twenty":-16.545624,"median":-12.97097,"eighty":-9.054369,"marketCap":1504699420},{"date":"2021-10-22","current":-18.493936,"twenty":-16.728002,"median":-13.052038,"eighty":-9.0546,"marketCap":1445208660},{"date":"2021-10-29","current":-19.487973,"twenty":-16.918658,"median":-13.192599,"eighty":-9.065511,"marketCap":1522887678},{"date":"2021-11-05","current":-21.694251,"twenty":-17.230296,"median":-13.217847,"eighty":-9.068239,"marketCap":1695297206},{"date":"2021-11-12","current":-20.979364,"twenty":-17.376546,"median":-13.248255,"eighty":-9.084018,"marketCap":1641173724},{"date":"2021-11-19","current":-21.018179,"twenty":-17.627693,"median":-13.306251,"eighty":-9.093008,"marketCap":1644210123},{"date":"2021-11-26","current":-18.59711,"twenty":-17.724892,"median":-13.36308,"eighty":-9.09439,"marketCap":1454814728},{"date":"2021-12-03","current":-17.903297,"twenty":-17.836807,"median":-13.397679,"eighty":-9.099442,"marketCap":1400539094},{"date":"2021-12-10","current":-19.009517,"twenty":-17.922319,"median":-13.461918,"eighty":-9.105715,"marketCap":1487076469},{"date":"2021-12-17","current":-21.411178,"twenty":-18.339089,"median":-13.523752,"eighty":-9.141289,"marketCap":1674953664},{"date":"2021-12-23","current":-21.576141,"twenty":-18.404686,"median":-13.538298,"eighty":-9.19146,"marketCap":1687858360},{"date":"2021-12-31","current":-21.187994,"twenty":-18.643832,"median":-13.635278,"eighty":-9.244088,"marketCap":1657494369},{"date":"2022-01-07","current":-16.535077,"twenty":-18.65535,"median":-13.71468,"eighty":-9.282247,"marketCap":1293506025},{"date":"2022-01-14","current":-15.273598,"twenty":-18.643832,"median":-13.796526,"eighty":-9.316764,"marketCap":1194823053},{"date":"2022-01-21","current":-13.614268,"twenty":-18.628162,"median":-13.763835,"eighty":-9.324228,"marketCap":1065016991},{"date":"2022-01-28","current":-11.940383,"twenty":-18.576475,"median":-13.688616,"eighty":-9.34366,"marketCap":934072279},{"date":"2022-02-04","current":-12.561419,"twenty":-18.478419,"median":-13.607802,"eighty":-9.350296,"marketCap":982654665},{"date":"2022-02-11","current":-11.285384,"twenty":-18.41052,"median":-13.552845,"eighty":-9.3572,"marketCap":882833044},{"date":"2022-02-18","current":-10.460571,"twenty":-18.383151,"median":-13.530363,"eighty":-9.371993,"marketCap":818309562},{"date":"2022-02-25","current":-10.741978,"twenty":-18.367013,"median":-13.519646,"eighty":-9.383827,"marketCap":840323456},{"date":"2022-03-04","current":-9.688638,"twenty":-18.346841,"median":-13.443599,"eighty":-9.410447,"marketCap":792220573},{"date":"2022-03-11","current":-10.270911,"twenty":-18.333921,"median":-13.396092,"eighty":-9.411627,"marketCap":839831858},{"date":"2022-03-18","current":-12.055911,"twenty":-18.155202,"median":-13.338179,"eighty":-9.438069,"marketCap":985787767},{"date":"2022-03-25","current":-10.30432,"twenty":-18.141037,"median":-13.280794,"eighty":-9.467655,"marketCap":842563653},{"date":"2022-04-01","current":-11.182502,"twenty":-18.091473,"median":-13.235825,"eighty":-9.492956,"marketCap":914370838},{"date":"2022-04-08","current":-10.084775,"twenty":-18.029445,"median":-13.217847,"eighty":-9.550229,"marketCap":824611857},{"date":"2022-04-14","current":-8.743823,"twenty":-17.966571,"median":-13.19269,"eighty":-9.432781,"marketCap":714964912},{"date":"2022-04-22","current":-7.813121,"twenty":-17.912808,"median":-13.077138,"eighty":-9.380868,"marketCap":638863297},{"date":"2022-04-29","current":-7.564934,"twenty":-17.890994,"median":-13.002219,"eighty":-9.337742,"marketCap":618569533},{"date":"2022-05-06","current":-7.426522,"twenty":-17.855642,"median":-12.966698,"eighty":-9.255063,"marketCap":607251857},{"date":"2022-05-13","current":-7.055067,"twenty":-17.833218,"median":-12.861335,"eighty":-9.106701,"marketCap":661292590},{"date":"2022-05-20","current":-5.626562,"twenty":-17.771363,"median":-12.813715,"eighty":-9.084018,"marketCap":527394503},{"date":"2022-05-27","current":-5.684868,"twenty":-17.745237,"median":-12.660732,"eighty":-9.054369,"marketCap":532859731},{"date":"2022-06-03","current":-4.801943,"twenty":-17.737028,"median":-12.627593,"eighty":-8.95124,"marketCap":450100564},{"date":"2022-06-10","current":-4.089773,"twenty":-17.730073,"median":-12.561419,"eighty":-8.884803,"marketCap":383346708},{"date":"2022-06-17","current":-3.781583,"twenty":-17.724892,"median":-12.459267,"eighty":-8.824644,"marketCap":354459074},{"date":"2022-06-24","current":-4.881073,"twenty":-17.720352,"median":-12.408239,"eighty":-8.7684,"marketCap":457517659},{"date":"2022-07-01","current":-4.822767,"twenty":-17.684176,"median":-12.274934,"eighty":-8.715717,"marketCap":452052431},{"date":"2022-07-08","current":-7.17168,"twenty":-17.633745,"median":-12.248836,"eighty":-8.692608,"marketCap":672223046},{"date":"2022-07-15","current":-7.196668,"twenty":-17.617007,"median":-12.144125,"eighty":-8.612608,"marketCap":674565287},{"date":"2022-07-22","current":-8.458584,"twenty":-17.576513,"median":-12.055911,"eighty":-8.581377,"marketCap":792848436},{"date":"2022-07-29","current":-7.221656,"twenty":-17.524355,"median":-11.894179,"eighty":-8.56331,"marketCap":676907527},{"date":"2022-08-05","current":-9.512263,"twenty":-17.400753,"median":-11.861399,"eighty":-8.555407,"marketCap":891612914},{"date":"2022-08-12","current":-8.625805,"twenty":-17.350322,"median":-11.769735,"eighty":-8.539628,"marketCap":955350999},{"date":"2022-08-19","current":-6.788501,"twenty":-17.27656,"median":-11.657921,"eighty":-8.520336,"marketCap":751860455},{"date":"2022-08-26","current":-6.933087,"twenty":-17.270113,"median":-11.575505,"eighty":-8.459312,"marketCap":767874106},{"date":"2022-09-02","current":-5.698815,"twenty":-17.254503,"median":-11.411593,"eighty":-8.433116,"marketCap":631172205},{"date":"2022-09-09","current":-5.543649,"twenty":-17.222227,"median":-11.316139,"eighty":-8.402544,"marketCap":613986823},{"date":"2022-09-16","current":-5.099311,"twenty":-17.176839,"median":-11.219387,"eighty":-8.38282,"marketCap":564774139},{"date":"2022-09-23","current":-5.205105,"twenty":-17.156666,"median":-11.106139,"eighty":-8.343685,"marketCap":576491445},{"date":"2022-09-30","current":-6.330057,"twenty":-16.959985,"median":-11.073112,"eighty":-8.269405,"marketCap":701085463},{"date":"2022-10-07","current":-10.755807,"twenty":-16.908326,"median":-11.043041,"eighty":-8.269405,"marketCap":1191259423},{"date":"2022-10-14","current":-10.526585,"twenty":-16.889381,"median":-10.983634,"eighty":-8.297841,"marketCap":1165871927},{"date":"2022-10-21","current":-10.932132,"twenty":-16.806498,"median":-10.958184,"eighty":-8.303923,"marketCap":1210788266},{"date":"2022-10-28","current":-11.542215,"twenty":-16.768347,"median":-10.953974,"eighty":-8.322526,"marketCap":1278358062},{"date":"2022-11-04","current":-10.914499,"twenty":-16.717916,"median":-10.967397,"eighty":-8.343685,"marketCap":1208835381},{"date":"2022-11-11","current":-11.344191,"twenty":-16.647312,"median":-10.962791,"eighty":-8.354397,"marketCap":1423695985},{"date":"2022-11-18","current":-10.049794,"twenty":-16.62714,"median":-10.967397,"eighty":-8.354465,"marketCap":1261249181},{"date":"2022-11-25","current":-10.525216,"twenty":-16.611581,"median":-10.949764,"eighty":-8.365585,"marketCap":1320914629},{"date":"2022-12-02","current":-11.278257,"twenty":-16.580652,"median":-10.937999,"eighty":-8.379929,"marketCap":1415421215},{"date":"2022-12-09","current":-9.435563,"twenty":-16.54284,"median":-10.900911,"eighty":-8.38732,"marketCap":1184163164},{"date":"2022-12-16","current":-9.373099,"twenty":-16.531101,"median":-10.878658,"eighty":-8.393763,"marketCap":1176323908},{"date":"2022-12-23","current":-8.609648,"twenty":-16.490733,"median":-10.784251,"eighty":-8.401054,"marketCap":1080510779},{"date":"2022-12-30","current":-8.550654,"twenty":-16.480889,"median":-10.755807,"eighty":-8.386195,"marketCap":1073107038},{"date":"2023-01-06","current":-8.026649,"twenty":-16.471483,"median":-10.69346,"eighty":-8.360025,"marketCap":1007344390},{"date":"2023-01-13","current":-8.210571,"twenty":-16.426351,"median":-10.672935,"eighty":-8.338773,"marketCap":1030426644},{"date":"2023-01-20","current":-8.391023,"twenty":-16.377843,"median":-10.653608,"eighty":-8.307919,"marketCap":1053073383},{"date":"2023-01-27","current":-9.418212,"twenty":-16.362213,"median":-10.622351,"eighty":-8.325121,"marketCap":1181985593},{"date":"2023-02-03","current":-8.953201,"twenty":-16.33033,"median":-10.598102,"eighty":-8.337136,"marketCap":1123626687},{"date":"2023-02-10","current":-8.016238,"twenty":-16.291538,"median":-10.582191,"eighty":-8.307919,"marketCap":1006037848},{"date":"2023-02-17","current":-8.311208,"twenty":-16.132459,"median":-10.5517,"eighty":-8.275092,"marketCap":1043056556},{"date":"2023-02-24","current":-8.030119,"twenty":-16.054745,"median":-10.525901,"eighty":-8.231392,"marketCap":1007779905},{"date":"2023-03-03","current":-8.387553,"twenty":-15.986664,"median":-10.497454,"eighty":-8.231392,"marketCap":1052637869},{"date":"2023-03-10","current":-6.435629,"twenty":-15.890044,"median":-10.456763,"eighty":-8.19669,"marketCap":934620687},{"date":"2023-03-17","current":-6.270613,"twenty":-15.797914,"median":-10.414026,"eighty":-8.099523,"marketCap":910656054},{"date":"2023-03-24","current":-5.790566,"twenty":-15.764767,"median":-10.407228,"eighty":-8.067817,"marketCap":840940758},{"date":"2023-03-31","current":-5.661554,"twenty":-15.730029,"median":-10.399775,"eighty":-8.033589,"marketCap":822204772},{"date":"2023-04-06","current":-5.208509,"twenty":-15.644351,"median":-10.35682,"eighty":-8.023608,"marketCap":756410961},{"date":"2023-04-14","current":-5.499418,"twenty":-15.574223,"median":-10.30432,"eighty":-7.994722,"marketCap":798658421},{"date":"2023-04-21","current":-5.892662,"twenty":-15.521886,"median":-10.270911,"eighty":-7.963641,"marketCap":855767729},{"date":"2023-04-28","current":-6.192849,"twenty":-15.371285,"median":-10.226889,"eighty":-7.840005,"marketCap":899362621},{"date":"2023-05-05","current":-8.07802,"twenty":-15.311904,"median":-10.209425,"eighty":-7.808348,"marketCap":1173138543},{"date":"2023-05-12","current":-6.709665,"twenty":-15.280047,"median":-10.16535,"eighty":-7.729148,"marketCap":1092923942},{"date":"2023-05-19","current":-6.50133,"twenty":-15.255016,"median":-10.150431,"eighty":-7.546255,"marketCap":1058988661},{"date":"2023-05-26","current":-6.166624,"twenty":-15.230664,"median":-10.123541,"eighty":-7.399027,"marketCap":1004469064},{"date":"2023-06-02","current":-6.482587,"twenty":-15.150093,"median":-10.101438,"eighty":-7.301546,"marketCap":1055935564},{"date":"2023-06-09","current":-6.578982,"twenty":-15.099664,"median":-10.081052,"eighty":-7.190357,"marketCap":1071637208},{"date":"2023-06-16","current":-7.449218,"twenty":-15.081916,"median":-10.06194,"eighty":-7.181675,"marketCap":1213388161},{"date":"2023-06-23","current":-7.130577,"twenty":-15.043354,"median":-10.049658,"eighty":-7.147018,"marketCap":1161485505},{"date":"2023-06-30","current":-6.889589,"twenty":-14.978471,"median":-10.010787,"eighty":-7.109449,"marketCap":1122231394},{"date":"2023-07-07","current":-6.694121,"twenty":-14.879324,"median":-10.003176,"eighty":-7.080055,"marketCap":1090391950},{"date":"2023-07-14","current":-6.71822,"twenty":-14.813575,"median":-9.929589,"eighty":-7.055067,"marketCap":1094317361},{"date":"2023-07-21","current":-6.734286,"twenty":-14.720843,"median":-9.757019,"eighty":-7.020794,"marketCap":1096934301},{"date":"2023-07-28","current":-5.612351,"twenty":-14.603223,"median":-9.723592,"eighty":-6.959208,"marketCap":914184610},{"date":"2023-08-04","current":-5.398139,"twenty":-14.56955,"median":-9.684017,"eighty":-6.913688,"marketCap":879292068},{"date":"2023-08-11","current":-4.03189,"twenty":-14.558043,"median":-9.636138,"eighty":-6.825667,"marketCap":694323632},{"date":"2023-08-18","current":-4.184036,"twenty":-14.524162,"median":-9.629385,"eighty":-6.795871,"marketCap":720524524},{"date":"2023-08-25","current":-4.754587,"twenty":-14.503242,"median":-9.590932,"eighty":-6.760289,"marketCap":818777868},{"date":"2023-09-01","current":-5.426568,"twenty":-14.469299,"median":-9.50261,"eighty":-6.734286,"marketCap":934498474},{"date":"2023-09-08","current":-5.464605,"twenty":-14.447925,"median":-9.46202,"eighty":-6.706556,"marketCap":941048697},{"date":"2023-09-15","current":-5.071559,"twenty":-14.422502,"median":-9.438069,"eighty":-6.644838,"marketCap":873363060},{"date":"2023-09-22","current":-4.949842,"twenty":-14.389111,"median":-9.414919,"eighty":-6.609239,"marketCap":852402346},{"date":"2023-09-29","current":-4.617655,"twenty":-14.346133,"median":-9.407047,"eighty":-6.577375,"marketCap":795197066},{"date":"2023-10-06","current":-4.749515,"twenty":-14.31098,"median":-9.378463,"eighty":-6.507756,"marketCap":817904505},{"date":"2023-10-13","current":-4.513688,"twenty":-14.290456,"median":-9.369034,"eighty":-6.480396,"marketCap":777293123},{"date":"2023-10-20","current":-4.009068,"twenty":-14.254834,"median":-9.345778,"eighty":-6.435381,"marketCap":690393498},{"date":"2023-10-27","current":-3.867064,"twenty":-14.245721,"median":-9.330985,"eighty":-6.382845,"marketCap":665939333},{"date":"2023-11-03","current":-4.062319,"twenty":-14.23073,"median":-9.300224,"eighty":-6.304458,"marketCap":699563811},{"date":"2023-11-10","current":-4.235537,"twenty":-14.186119,"median":-9.266506,"eighty":-6.270701,"marketCap":799127199},{"date":"2023-11-17","current":-5.26616,"twenty":-14.175985,"median":-9.233113,"eighty":-6.246101,"marketCap":993576892},{"date":"2023-11-24","current":-5.148354,"twenty":-14.166482,"median":-9.221106,"eighty":-6.167838,"marketCap":971350279},{"date":"2023-12-01","current":-5.206004,"twenty":-14.131341,"median":-9.105221,"eighty":-6.111798,"marketCap":982227132},{"date":"2023-12-08","current":-6.356488,"twenty":-14.04259,"median":-9.094269,"eighty":-6.096789,"marketCap":1199291289},{"date":"2023-12-15","current":-6.902905,"twenty":-14.028044,"median":-9.068239,"eighty":-6.096789,"marketCap":1302384941},{"date":"2023-12-22","current":-7.489427,"twenty":-14.025921,"median":-9.0546,"eighty":-6.100835,"marketCap":1413045100},{"date":"2023-12-29","current":-8.757716,"twenty":-14.008907,"median":-9.009394,"eighty":-6.107413,"marketCap":1652335870},{"date":"2024-01-05","current":-9.281575,"twenty":-13.987173,"median":-9.0546,"eighty":-6.120086,"marketCap":1751173361},{"date":"2024-01-12","current":-9.274056,"twenty":-13.943671,"median":-9.061419,"eighty":-6.154509,"marketCap":1749754642},{"date":"2024-01-19","current":-8.211299,"twenty":-13.935913,"median":-9.054023,"eighty":-6.159602,"marketCap":1549242218},{"date":"2024-01-26","current":-9.416751,"twenty":-13.905441,"median":-9.0546,"eighty":-6.166624,"marketCap":1776677287},{"date":"2024-02-02","current":-9.534775,"twenty":-13.893773,"median":-9.068239,"eighty":-6.167838,"marketCap":1798944976},{"date":"2024-02-09","current":-9.356484,"twenty":-13.878644,"median":-9.094269,"eighty":-6.192849,"marketCap":1765306552},{"date":"2024-02-16","current":-9.539797,"twenty":-13.835161,"median":-9.100679,"eighty":-6.225609,"marketCap":1799892537},{"date":"2024-02-23","current":-9.625175,"twenty":-13.830421,"median":-9.105273,"eighty":-6.230052,"marketCap":1816001078},{"date":"2024-03-01","current":-7.192485,"twenty":-13.817912,"median":-9.107687,"eighty":-6.241337,"marketCap":1735985333},{"date":"2024-03-08","current":-7.02362,"twenty":-13.807049,"median":-9.100679,"eighty":-6.252765,"marketCap":1695227829},{"date":"2024-03-15","current":-6.870463,"twenty":-13.801122,"median":-9.094269,"eighty":-6.255798,"marketCap":1658261720},{"date":"2024-03-22","current":-6.866535,"twenty":-13.794357,"median":-9.068239,"eighty":-6.258187,"marketCap":1657313871},{"date":"2024-03-28","current":-6.901879,"twenty":-13.75802,"median":-9.0546,"eighty":-6.261305,"marketCap":1665844512},{"date":"2024-04-05","current":-6.803702,"twenty":-13.722712,"median":-8.965343,"eighty":-6.267575,"marketCap":1642148288},{"date":"2024-04-12","current":-6.876353,"twenty":-13.699042,"median":-8.949082,"eighty":-6.270876,"marketCap":1659683493},{"date":"2024-04-19","current":-6.764431,"twenty":-13.676978,"median":-8.940031,"eighty":-6.285296,"marketCap":1632669799},{"date":"2024-04-26","current":-6.693743,"twenty":-13.636249,"median":-8.888993,"eighty":-6.295007,"marketCap":1615608518},{"date":"2024-05-03","current":-6.678035,"twenty":-13.606508,"median":-8.861134,"eighty":-6.300411,"marketCap":1611817122},{"date":"2024-05-10","current":-6.811556,"twenty":-13.591628,"median":-8.831645,"eighty":-6.305537,"marketCap":1644043986},{"date":"2024-05-17","current":-6.66535,"twenty":-13.56577,"median":-8.821685,"eighty":-6.320681,"marketCap":1807342945},{"date":"2024-05-24","current":-6.607374,"twenty":-13.544117,"median":-8.774994,"eighty":-6.333212,"marketCap":1791622362},{"date":"2024-05-31","current":-6.591913,"twenty":-13.536996,"median":-8.765808,"eighty":-6.33955,"marketCap":1787430207},{"date":"2024-06-07","current":-1.428017,"twenty":-13.534391,"median":-8.762512,"eighty":-6.320681,"marketCap":235088680},{"date":"2024-06-14","current":-1.458793,"twenty":-13.530648,"median":-8.74769,"eighty":-6.294936,"marketCap":240155247},{"date":"2024-06-21","current":-1.274136,"twenty":-13.527902,"median":-8.742788,"eighty":-6.264538,"marketCap":209755848},{"date":"2024-06-28","current":-1.236325,"twenty":-13.525827,"median":-8.73905,"eighty":-6.257641,"marketCap":203531210},{"date":"2024-07-05","current":-1.181807,"twenty":-13.520467,"median":-8.720695,"eighty":-6.23625,"marketCap":194556149},{"date":"2024-07-12","current":-1.1651,"twenty":-13.501419,"median":-8.701753,"eighty":-6.16711,"marketCap":191805728},{"date":"2024-07-15","current":-1.168617,"twenty":-13.494359,"median":-8.700162,"eighty":-6.163815,"marketCap":192384764},{"date":"2024-08-02","current":-1.28117,"twenty":-13.487298,"median":-8.699924,"eighty":-6.158329,"marketCap":210913921},{"date":"2024-08-09","current":-1.005943,"twenty":-13.450927,"median":-8.696095,"eighty":-6.09615,"marketCap":165604341},{"date":"2024-08-16","current":0.104301,"twenty":-13.431551,"median":-8.6648,"eighty":-6.071261,"marketCap":179428830},{"date":"2024-08-23","current":0.109307,"twenty":-13.403851,"median":-8.63741,"eighty":-5.995926,"marketCap":188041992},{"date":"2024-08-30","current":0.117049,"twenty":-13.39514,"median":-8.624442,"eighty":-5.904035,"marketCap":201359824},{"date":"2024-09-06","current":0.134972,"twenty":-13.390591,"median":-8.609648,"eighty":-5.798831,"marketCap":232193500},{"date":"2024-09-13","current":0.126894,"twenty":-13.3581,"median":-8.599787,"eighty":-5.718185,"marketCap":218296632},{"date":"2024-09-20","current":0.147174,"twenty":-13.320535,"median":-8.57594,"eighty":-5.693236,"marketCap":253183560},{"date":"2024-09-27","current":0.128998,"twenty":-13.305746,"median":-8.560338,"eighty":-5.649553,"marketCap":221915608},{"date":"2024-10-04","current":0.125211,"twenty":-13.276207,"median":-8.555407,"eighty":-5.607263,"marketCap":215401451},{"date":"2024-10-11","current":0.131102,"twenty":-13.252097,"median":-8.535683,"eighty":-5.58388,"marketCap":225534584},{"date":"2024-10-18","current":0.136066,"twenty":-13.240797,"median":-8.522393,"eighty":-5.549996,"marketCap":234075367},{"date":"2024-10-25","current":0.129334,"twenty":-13.231179,"median":-8.49513,"eighty":-5.503238,"marketCap":222494644},{"date":"2024-10-31","current":0.137076,"twenty":-13.224048,"median":-8.462226,"eighty":-5.484857,"marketCap":235812476},{"date":"2024-11-08","current":0.136824,"twenty":-13.217877,"median":-8.459506,"eighty":-5.448787,"marketCap":235378199},{"date":"2024-11-15","current":0.12003,"twenty":-13.207731,"median":-8.443665,"eighty":-5.380467,"marketCap":207439704},{"date":"2024-11-22","current":0.117098,"twenty":-13.192708,"median":-8.434596,"eighty":-5.31642,"marketCap":202373137},{"date":"2024-11-29","current":0.12782,"twenty":-13.171515,"median":-8.426987,"eighty":-5.264154,"marketCap":220902295},{"date":"2024-12-06","current":0.12648,"twenty":-13.08517,"median":-8.411844,"eighty":-5.216231,"marketCap":218586150},{"date":"2024-12-13","current":0.123548,"twenty":-13.067098,"median":-8.398818,"eighty":-5.199699,"marketCap":213519584},{"date":"2024-12-20","current":0.116261,"twenty":-13.024078,"median":-8.388445,"eighty":-5.177816,"marketCap":200925547},{"date":"2024-12-27","current":0.12514,"twenty":-13.01264,"median":-8.38282,"eighty":-5.148354,"marketCap":216270005},{"date":"2025-01-03","current":0.127736,"twenty":-12.995966,"median":-8.368365,"eighty":-5.142063,"marketCap":220757536},{"date":"2025-01-10","current":0.125475,"twenty":-12.979301,"median":-8.354397,"eighty":-5.097874,"marketCap":216849041},{"date":"2025-01-17","current":0.113413,"twenty":-12.968407,"median":-8.346533,"eighty":-5.070194,"marketCap":196003740},{"date":"2025-01-24","current":0.109644,"twenty":-12.940438,"median":-8.330294,"eighty":-5.039101,"marketCap":189489583},{"date":"2025-01-31","current":0.113497,"twenty":-12.895226,"median":-8.311208,"eighty":-4.971878,"marketCap":196148499},{"date":"2025-02-07","current":0.108471,"twenty":-12.866366,"median":-8.300882,"eighty":-4.937061,"marketCap":187462956},{"date":"2025-02-14","current":0.110063,"twenty":-12.829543,"median":-8.262624,"eighty":-4.888294,"marketCap":190213378},{"date":"2025-02-21","current":0.107215,"twenty":-12.818415,"median":-8.231392,"eighty":-4.86555,"marketCap":185291571},{"date":"2025-02-28","current":0.105539,"twenty":-12.791099,"median":-8.210935,"eighty":-4.812772,"marketCap":182396390},{"date":"2025-03-07","current":0.11157,"twenty":-12.69316,"median":-8.180554,"eighty":-4.789981,"marketCap":192819041},{"date":"2025-03-14","current":0.118522,"twenty":-12.662245,"median":-8.128541,"eighty":-4.744813,"marketCap":204834041},{"date":"2025-03-21","current":0.120949,"twenty":-12.654648,"median":-8.099523,"eighty":-4.702077,"marketCap":204110246},{"date":"2025-03-28","current":0.122836,"twenty":-12.635275,"median":-8.082172,"eighty":-4.65634,"marketCap":207294945},{"date":"2025-04-04","current":0.114344,"twenty":-12.608867,"median":-8.067817,"eighty":-4.615626,"marketCap":192963800},{"date":"2025-04-11","current":0.097102,"twenty":-12.580425,"median":-8.059594,"eighty":-4.551429,"marketCap":163867233},{"date":"2025-04-17","current":0.098389,"twenty":-12.561419,"median":-8.031854,"eighty":-4.48833,"marketCap":166038618},{"date":"2025-04-25","current":0.102764,"twenty":-12.551715,"median":-8.025451,"eighty":-4.412256,"marketCap":173421329},{"date":"2025-05-02","current":0.10568,"twenty":-12.478937,"median":-8.000315,"eighty":-4.235537,"marketCap":178343137},{"date":"2025-05-09","current":0.096588,"twenty":-12.439597,"median":-7.991946,"eighty":-4.089773,"marketCap":162998679},{"date":"2025-05-16","current":0.100989,"twenty":-12.434577,"median":-7.97539,"eighty":-4.044568,"marketCap":174000366},{"date":"2025-05-23","current":0.105357,"twenty":-12.381901,"median":-7.908838,"eighty":-3.993853,"marketCap":181527836},{"date":"2025-05-30","current":0.115524,"twenty":-12.32239,"median":-7.842802,"eighty":-3.849968,"marketCap":199043680},{"date":"2025-06-06","current":0.108298,"twenty":-12.28145,"median":-7.820969,"eighty":-3.684995,"marketCap":186594402},{"date":"2025-06-13","current":0.120397,"twenty":-12.27012,"median":-7.741529,"eighty":-1.480952,"marketCap":207439704},{"date":"2025-06-20","current":0.12779,"twenty":-12.256868,"median":-7.679625,"eighty":-1.456331,"marketCap":220178499},{"date":"2025-06-27","current":0.124261,"twenty":-12.215704,"median":-7.603614,"eighty":-1.340788,"marketCap":214098620},{"date":"2025-07-03","current":0.1372,"twenty":-12.181568,"median":-7.503213,"eighty":-1.260418,"marketCap":236391512},{"date":"2025-07-11","current":0.176268,"twenty":-12.147999,"median":-7.450386,"eighty":-1.219442,"marketCap":303704465},{"date":"2025-07-18","current":0.198448,"twenty":-12.097216,"median":-7.41608,"eighty":-1.173893,"marketCap":341920852},{"date":"2025-07-25","current":0.193827,"twenty":-12.055911,"median":-7.368888,"eighty":-1.136258,"marketCap":333959105},{"date":"2025-08-01","current":0.184165,"twenty":-12.0097,"median":-7.300695,"eighty":-1.006646,"marketCap":317311815},{"date":"2025-08-08","current":0.179293,"twenty":-11.932996,"median":-7.27517,"eighty":0.093431,"marketCap":308915791},{"date":"2025-08-15","current":-2.118471,"twenty":-11.899726,"median":-7.210926,"eighty":0.095163,"marketCap":346780978},{"date":"2025-08-22","current":-2.137939,"twenty":-11.899726,"median":-7.188912,"eighty":0.095163,"marketCap":349967771},{"date":"2025-08-29","current":-2.467125,"twenty":-11.899726,"median":-7.117001,"eighty":0.095163,"marketCap":403853537},{"date":"2025-09-05","current":-2.452966,"twenty":-11.910821,"median":-7.080055,"eighty":0.095189,"marketCap":401535870},{"date":"2025-09-12","current":-2.517565,"twenty":-11.899726,"median":-7.052928,"eighty":0.095163,"marketCap":412110227},{"date":"2025-09-19","current":-2.358281,"twenty":-11.899726,"median":-7.022207,"eighty":0.095163,"marketCap":386036469},{"date":"2025-09-26","current":-2.817991,"twenty":-11.899726,"median":-6.994363,"eighty":0.095163,"marketCap":461288231},{"date":"2025-10-03","current":-3.102932,"twenty":-11.899726,"median":-6.957161,"eighty":0.095163,"marketCap":507931287},{"date":"2025-10-10","current":-3.09718,"twenty":-11.899726,"median":-6.916619,"eighty":0.095163,"marketCap":506989735},{"date":"2025-10-17","current":-3.238323,"twenty":-11.899726,"median":-6.888862,"eighty":0.095163,"marketCap":530093981},{"date":"2025-10-24","current":-2.5096,"twenty":-11.899726,"median":-6.871444,"eighty":0.095163,"marketCap":410806539},{"date":"2025-10-31","current":-6.947417,"twenty":-11.899726,"median":-6.866535,"eighty":0.095163,"marketCap":1137250402},{"date":"2025-11-07","current":-7.166874,"twenty":-11.899726,"median":-6.866535,"eighty":0.095163,"marketCap":1173174246},{"date":"2025-11-14","current":-6.603187,"twenty":-11.899726,"median":-6.865553,"eighty":0.095163,"marketCap":1080902115},{"date":"2025-11-21","current":-7.487278,"twenty":-11.861937,"median":-6.865553,"eighty":0.095163,"marketCap":1161172041},{"date":"2025-11-28","current":-7.88865,"twenty":-11.742377,"median":-6.865553,"eighty":0.095163,"marketCap":1223419240},{"date":"2025-12-05","current":-8.197182,"twenty":-11.617777,"median":-6.865553,"eighty":0.095163,"marketCap":1271268138},{"date":"2025-12-12","current":-7.709533,"twenty":-11.403957,"median":-6.865553,"eighty":0.095163,"marketCap":1195640700},{"date":"2025-12-19","current":-8.001185,"twenty":-11.337354,"median":-6.865553,"eighty":0.095163,"marketCap":1240871726},{"date":"2025-12-26","current":-7.536043,"twenty":-11.289254,"median":-6.865553,"eighty":0.095163,"marketCap":1168734785},{"date":"2026-01-02","current":-7.408504,"twenty":-11.181733,"median":-6.865553,"eighty":0.095163,"marketCap":1148955302},{"date":"2026-01-09","current":-7.052146,"twenty":-11.074324,"median":-6.865553,"eighty":0.095163,"marketCap":1093689097},{"date":"2026-01-16","current":-6.733299,"twenty":-10.974222,"median":-6.860645,"eighty":0.095163,"marketCap":1044240388},{"date":"2026-01-23","current":-7.454456,"twenty":-10.939172,"median":-6.859408,"eighty":0.095163,"marketCap":1156081733},{"date":"2026-01-30","current":-6.804571,"twenty":-10.880889,"median":-6.848864,"eighty":0.095163,"marketCap":1055293629},{"date":"2026-02-06","current":-7.645764,"twenty":-10.722571,"median":-6.848864,"eighty":0.095163,"marketCap":1185750959},{"date":"2026-02-13","current":-7.700156,"twenty":-10.655341,"median":-6.848864,"eighty":0.095163,"marketCap":1194186327},{"date":"2026-02-20","current":-7.603564,"twenty":-10.601716,"median":-6.848864,"eighty":0.095163,"marketCap":1179206277},{"date":"2026-02-27","current":-7.242516,"twenty":-10.568541,"median":-6.848864,"eighty":0.095163,"marketCap":1123212885},{"date":"2026-03-06","current":-6.626391,"twenty":-10.505783,"median":-6.845284,"eighty":0.095163,"marketCap":1027660527},{"date":"2026-03-13","current":-6.498853,"twenty":-10.428161,"median":-6.829185,"eighty":0.095163,"marketCap":1007881043},{"date":"2026-03-20","current":-6.765617,"twenty":-10.386411,"median":-6.812729,"eighty":0.095163,"marketCap":947558425},{"date":"2026-03-27","current":-6.861568,"twenty":-10.343704,"median":-6.806916,"eighty":0.095163,"marketCap":960996898},{"date":"2026-04-02","current":-6.99298,"twenty":-10.343704,"median":-6.799786,"eighty":0.095163,"marketCap":979401763},{"date":"2026-04-10","current":-7.900346,"twenty":-10.298288,"median":-6.792174,"eighty":0.095163,"marketCap":1106482977},{"date":"2026-04-17","current":-8.667957,"twenty":-10.251785,"median":-6.792174,"eighty":0.095163,"marketCap":1213990761},{"date":"2026-04-24","current":-12.508099,"twenty":-10.281908,"median":-6.792174,"eighty":0.095163,"marketCap":1751821827},{"date":"2026-05-01","current":-13.476187,"twenty":-10.362548,"median":-6.792174,"eighty":0.095163,"marketCap":1887407424},{"date":"2026-05-08","current":-12.987035,"twenty":-10.481137,"median":-6.792174,"eighty":0.095163,"marketCap":1818899252},{"date":"2026-05-15","current":-13.09064,"twenty":-10.541397,"median":-6.792174,"eighty":0.095163,"marketCap":1704204965},{"date":"2026-05-22","current":-12.460675,"twenty":-10.629123,"median":-6.792174,"eighty":0.095163,"marketCap":1622193036},{"date":"2026-05-29","current":-11.718016,"twenty":-10.669392,"median":-6.788501,"eighty":0.095189,"marketCap":1525509920},{"date":"2026-06-05","current":-10.28341,"twenty":-10.673287,"median":-6.792174,"eighty":0.095163,"marketCap":1338745722},{"date":"2026-06-12","current":-10.541481,"twenty":-10.587946,"median":-6.792174,"eighty":0.095163,"marketCap":1372342738},{"date":"2026-06-18","current":-10.61586,"twenty":-10.547355,"median":-6.792174,"eighty":0.095163,"marketCap":1382025721},{"date":"2026-06-26","current":-10.740951,"twenty":-10.52306,"median":-6.788501,"eighty":0.095189,"marketCap":1398310737},{"date":"2026-07-02","current":-10.699254,"twenty":-10.52306,"median":-6.788501,"eighty":0.095189,"marketCap":1392882398},{"date":"2026-07-10","current":-11.703366,"twenty":-10.52306,"median":-6.788501,"eighty":0.095189,"marketCap":1523602666},{"date":"2026-07-17","current":-10.037735,"twenty":-10.494482,"median":-6.788501,"eighty":0.095189,"marketCap":1306762537},{"date":"2026-07-24","current":-9.579067,"twenty":-10.450596,"median":-6.788501,"eighty":0.095189,"marketCap":1247050810},{"date":"2026-07-31","current":-9.548639,"twenty":-10.386526,"median":-6.78817,"eighty":0.095215,"marketCap":1243089589},{"date":"2026-08-07","current":-9.668096,"twenty":-10.28924,"median":-6.78817,"eighty":0.095215,"marketCap":1258641046},{"date":"2026-08-14","current":-10.967164,"twenty":-10.28341,"median":-6.78817,"eighty":0.095215,"marketCap":1427760196},{"date":"2026-08-21","current":-10.560468,"twenty":-10.261366,"median":-6.78817,"eighty":0.095215,"marketCap":1459255989}],"updateTime":1787495301391},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INBX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643206186","title":"Inhibrx Biosciences - FDA Sets Pdufa Goal Date of April 14, 2027 for Ozekibart Bla","url":"https://stock-news.laohu8.com/highlight/detail?id=2643206186","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643206186?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:15","pubTimestamp":1781529300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUADPNKC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640918255","title":"Inhibrx Biosciences Holds 2026 Virtual Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640918255","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640918255?lang=en_us&edition=fundamental","pubTime":"2026-06-04 05:14","pubTimestamp":1780521286,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences Inc ( ($INBX) ) has provided an announcement. Inhibrx Biosciences Inc. held its 2026 Annual Meeting of Stockholders on June 3, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-holds-2026-virtual-annual-shareholder-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-holds-2026-virtual-annual-shareholder-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640189059","title":"Inhibrx Biosciences shareholders elect two Class II directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640189059","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640189059?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:03","pubTimestamp":1780517009,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences held its annual stockholder meeting on June 3, 2026.Stockholders backed the board’s director nominees for Class II seats.Stockholders ratified BDO USA, P.C. as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inhibrx Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL37mxgr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637687452","title":"Transcenta Gains Boost as Inhibrx’s Ozekibart Data and FDA Filing Strengthen Greater China Cancer Franchise","url":"https://stock-news.laohu8.com/highlight/detail?id=2637687452","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637687452?lang=en_us&edition=fundamental","pubTime":"2026-05-21 07:46","pubTimestamp":1779320794,"startTime":"0","endTime":"0","summary":"Transcenta Holding Limited ( ($HK:6628) ) has issued an update. Transcenta reported that its U.S. partner Inhibrx Biosciences has released updated ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcenta-gains-boost-as-inhibrxs-ozekibart-data-and-fda-filing-strengthen-greater-china-cancer-franchise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcenta-gains-boost-as-inhibrxs-ozekibart-data-and-fda-filing-strengthen-greater-china-cancer-franchise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4139","INBX","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635510066","title":"LifeSci Capital Reaffirms Their Buy Rating on Inhibrx Biosciences Inc (INBX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635510066","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635510066?lang=en_us&edition=fundamental","pubTime":"2026-05-16 22:35","pubTimestamp":1778942131,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Oliver McCammon maintained a Buy rating on Inhibrx Biosciences Inc today and set a price target of $230.00. McCammon covers...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-reaffirms-their-buy-rating-on-inhibrx-biosciences-inc-inbx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-reaffirms-their-buy-rating-on-inhibrx-biosciences-inc-inbx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635087773","title":"Inhibrx price target raised to $325 from $300 at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2635087773","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635087773?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:15","pubTimestamp":1778850911,"startTime":"0","endTime":"0","summary":"Stifel raised the firm’s price target on Inhibrx (INBX) to $325 from $300 and keeps a Buy rating on the shares. Published first on TheFly – the ult...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inhibrx-price-target-raised-to-325-from-300-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inhibrx-price-target-raised-to-325-from-300-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INBX","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635087533","title":"Stifel Nicolaus Sticks to Their Buy Rating for Inhibrx Biosciences Inc (INBX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635087533","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635087533?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:45","pubTimestamp":1778849125,"startTime":"0","endTime":"0","summary":"In a report released today, Dara Azar from Stifel Nicolaus reiterated a Buy rating on Inhibrx Biosciences Inc, with a price target of $325.00. Acco...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-sticks-to-their-buy-rating-for-inhibrx-biosciences-inc-inbx-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-sticks-to-their-buy-rating-for-inhibrx-biosciences-inc-inbx-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INBX","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635089727","title":"Inhibrx Biosciences Inc : Stifel Raises Target Price to $325 From $300","url":"https://stock-news.laohu8.com/highlight/detail?id=2635089727","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635089727?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:43","pubTimestamp":1778845429,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nFWN41S111:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635061721","title":"Inhibrx reports Q1 EPS ($2.15) vs. ($2.80) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2635061721","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635061721?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:48","pubTimestamp":1778795289,"startTime":"0","endTime":"0","summary":"As of March 31, 2026, the company had cash and cash equivalents of $161.7M, as compared to $124.2M as of December 31, 2025. Published first on TheF...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inhibrx-reports-q1-eps-2-15-vs-2-80-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inhibrx-reports-q1-eps-2-15-vs-2-80-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635729832","title":"Inhibrx Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635729832","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635729832?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:58","pubTimestamp":1778792329,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences Inc reports results for the quarter ended March 31 - Earnings SummaryInhibrx Biosciences Inc INBX.OQ reported a quarterly adjusted loss of $2.15 per share for the quarter ended Mar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL8N41R2J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635726673","title":"Inhibrx Biosciences Q1 EPS $(2.15) Misses $(1.79) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635726673","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635726673?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:38","pubTimestamp":1778791097,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences (NASDAQ:INBX) reported quarterly losses of $(2.15) per share which missed the analyst consensus estimate of $(1.79) by 20.11 percent. This is a 23.21 percent increase over losses of $(2.80) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52582394/inhibrx-biosciences-q1-eps-2-15-misses-1-79-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Inhibrx Biosciences Q1 EPS $(2.15) Misses $(1.79) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635723190","title":"Inhibrx Q1 net loss narrows as R&D costs fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2635723190","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635723190?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:09","pubTimestamp":1778789386,"startTime":"0","endTime":"0","summary":"Inhibrx Q1 net loss narrows as R&D costs fallOverviewUS biopharmaceutical company's Q1 net loss narrowed yr/yr as R&D expenses declinedCompany's Q1 R&D expenses fell, mainly due to lower clinical tria","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL1N41R18O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635236627","title":"Inhibrx net loss narrows 23% to $33.44 million in Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635236627","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635236627?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:04","pubTimestamp":1778789068,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences posted a Q1 net loss of USD 33.44 million, narrowing 23% from a year earlier.Operating loss improved as total operating expense fell 28% to USD 30.93 million, led by research and development spending dropping 32% to USD 25.22 million.Cash and cash equivalents totaled USD 161.7 million at March 31, 2026, while net cash used in operating activities increased to USD 38.03 million from USD 35.9 million.In April 2026, ozekibart Phase 1/2 interim data in combination with FOLFIRI in unresectable colorectal cancer showed a 20% objective response rate in 45 evaluable patients; a biologics license application was submitted to FDA in April 2026 for conventional chondrosarcoma.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL64lnG1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635728790","title":"Inhibrx Q1 Net Income USD -33.441 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635728790","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635728790?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:02","pubTimestamp":1778788920,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nPLX8ABE73:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635287137","title":"Inhibrx Q1 Operating Income USD -30.927 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635287137","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635287137?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:02","pubTimestamp":1778788920,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nPLX8ABE73:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634726887","title":"Should Positive INBRX-106 Phase 2 Combo Data in Head and Neck Cancer Require Action From Inhibrx Biosciences (INBX) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2634726887","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634726887?lang=en_us&edition=fundamental","pubTime":"2026-05-12 08:33","pubTimestamp":1778546019,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences recently reported positive interim Phase 2 data from the HexAgon study, where its hexavalent OX40 agonist INBRX-106 combined with pembrolizumab produced higher confirmed response rates and more complete responses than pembrolizumab alone in first-line PD-L1 high head and neck cancer patients.\nThese data, supported by strong T-cell activation signals and a generally manageable safety profile, have prompted plans for a Phase 3 trial and broader exploration of INBRX-106...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-inbx/inhibrx-biosciences/news/should-positive-inbrx-106-phase-2-combo-data-in-head-and-nec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-inbx/inhibrx-biosciences/news/should-positive-inbrx-106-phase-2-combo-data-in-head-and-nec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","AGIX","BK4023","BK4139","BK4543","BK4588","BK4585","BK4211","BK4528","AIPO","INBX","CHAT","AIYY","AI","BK4551","BK4587","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634253560","title":"Inhibrx Biosciences Reports Positive Interim Phase 2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2634253560","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634253560?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:13","pubTimestamp":1778534007,"startTime":"0","endTime":"0","summary":"An announcement from Inhibrx Biosciences Inc ( ($INBX) ) is now available. On May 11, 2026, Inhibrx Biosciences reported positive interim Phase 2 d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-reports-positive-interim-phase-2-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-reports-positive-interim-phase-2-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634623528","title":"Inhibrx’s INBRX-106 shows potential benefit in HNSCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2634623528","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634623528?lang=en_us&edition=fundamental","pubTime":"2026-05-12 00:20","pubTimestamp":1778516441,"startTime":"0","endTime":"0","summary":"Inhibrx (INBX) Biosciences announced positive interim results from the randomized, first-line Phase 2 portion of the HexAgon study. The trial evalu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inhibrxs-inbrx-106-shows-potential-benefit-in-hnscc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inhibrxs-inbrx-106-shows-potential-benefit-in-hnscc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634286211","title":"Inhibrx says INBRX-106 plus pembrolizumab lifts Phase 2 HNSCC response rate to 44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634286211","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634286211?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:03","pubTimestamp":1778500997,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences reported interim Phase 2 results from HexAgon, a first-line head and neck cancer study testing INBRX-106 with pembrolizumab versus pembrolizumab alone.Early readout showed the combination produced more confirmed tumor responses than PD-1 monotherapy, with deeper reductions in responding patients and complete responses seen only in the combination arm.Immune monitoring pointed to stronger systemic T-cell expansion with the combination, supporting a potential costimulatory effect beyond checkpoint inhibition alone.Safety was described as manageable for an immunotherapy combination, with no treatment-related deaths reported.Progression-free survival data are expected in Q4 2026; Phase 3 start is planned for Q3 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL3nQS80:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634928660","title":"Inhibrx Reports Interim Phase 2 Data for Inbrx-106 in First-Line Hnscc; Initial Results Demonstrate Potential Costimulatory Benefit Over Pd-1 Monotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2634928660","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634928660?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:00","pubTimestamp":1778500813,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUABVC6HW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":83,"code":"91000000","status":"200"}]}}